Announcements
- Predictive Oncology Announces Significant Progress with FluGen In the Development of First-of-Its-Kind Intranasal Flu Vaccine
- Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
- Predictive Oncology to Participate in Upcoming Investor Conferences
- Predictive Oncology to Participate in Upcoming San Francisco Conferences
- Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
- Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital
- Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023
- Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update
- Predictive Oncology to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on Thursday, August 10, 2023
More ▼
Key statistics
As of last trade, Predictive Oncology Inc (S1K:MUN) traded at 1.44, 22.03% above the 52 week low of 1.18 set on Apr 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.44 |
---|---|
High | 1.44 |
Low | 1.44 |
Bid | 1.45 |
Offer | 1.65 |
Previous close | 1.36 |
Average volume | 241.00 |
---|---|
Shares outstanding | 4.06m |
Free float | 3.92m |
P/E (TTM) | -- |
Market cap | 6.70m USD |
EPS (TTM) | -3.48 USD |
Data delayed at least 15 minutes, as of May 02 2024 07:04 BST.
More ▼